Hormonal Status in Postmenopausal Androgenetic Alopecia

December 1992 in “ International Journal of Dermatology ”

S. Georgala, K. Gourgiotou, S. Kassouli, John Stratigos

testosterone estradiol sex hormone binding globulin SHBG androgenetic alopecia androgen receptors hair follicle keratinocytes DHEA-S free testosterone 3,17-androstanediol glucuronide testosterone estradiol SHBG androgenic alopecia androgen receptors hair follicle cells DHEA-S free testosterone 3,17-androstanediol glucuronide

TLDR No significant hormone differences found in postmenopausal women with androgenetic alopecia.

This study aimed to determine the serum levels of testosterone, estradiol, and sex hormone binding globulin (SHBG) in postmenopausal women with androgenetic alopecia and healthy controls. The results showed no statistically significant differences in hormone levels between the two groups, suggesting that a genetically determined functional alteration of androgen receptors and/or a metabolic disturbance may exist in the hair follicle keratinocytes in androgenetic alopecia. The study contradicts previous findings that reported high serum concentrations of DHEA-S, free testosterone/SHBG, and 3,17-androstanediol glucuronide/SHBG ratios, as well as low SHBG levels in women with androgenetic alopecia.

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research Androgenic Alopecia in Females: Diagnosis and Treatment

14 citations , July 1987 in “Dermatologic Clinics”

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Female Androgenic Alopecia: The 3 Alpha, 17 Beta-Androstanediol Glucuronide/Sex Hormone Binding Globulin Ratio as a Possible Marker for Female Pattern Baldness

research Female Androgenic Alopecia: The 3 Alpha, 17 Beta-Androstanediol Glucuronide/Sex Hormone Binding Globulin Ratio as a Possible Marker for Female Pattern Baldness

13 citations , September 1986 in “Archives of Dermatology”

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Related Community Posts Join

6 / 1000+ results

community How I recovered from 4+ years of severe balding ages 20-24 by dieting, lifestyle changes and ONLY using topical minoxidil

in Progress Pictures 473 upvotes 2 months ago

A user reversed severe hair loss with dieting, lifestyle changes, and topical minoxidil, highlighting reduced inflammation and body fat. The conversation debates finasteride's effectiveness and the impact of diet and lifestyle on hair health.

community Be careful when switching from Finasteride to Dutasteride because for more efficacy.

in Finasteride/Dutasteride 13 upvotes 1 year ago

Switching from finasteride to dutasteride may be more effective for hair regrowth due to dutasteride's stronger enzyme inhibition, but combining both drugs could enhance results. Some users report better outcomes with dutasteride, while others recommend a gradual transition to prevent potential hair loss.

community Boys I am just a gonner. What on earth is my scalp even going through. Looks like world war 3. Pyril 3 months. Topical melitonin/progesterone/fin, dut, fin, oral min, laser trash, anus stimulation. Nothing. Donor area is decimated 😂.

in Progress Pictures 83 upvotes 2 years ago

Treating Seborrheic Dermatitis, a fungal scalp condition which can cause hair loss. Treatments discussed include antifungal shampoos, cold showers, exfoliating the scalp, taking Vitamin D, and stimulating the prostate through the anus.

community Female, 27 years old, shedding/ balding despite being on what is considered to be a effective treatment plan for AGA. Considering Dut (oral) . Please help.

in Finasteride/Dutasteride 27 upvotes 1 year ago

A 27-year-old woman with androgenic alopecia is losing hair despite using oral minoxidil and spironolactone, and is considering dutasteride. She is exploring causes like stress and medication side effects, planning tests, and considering treatment changes.

community What should I include in my blood test?

in Treatment 1 upvotes 1 week ago

The user has been using finasteride, dutasteride, and minoxidil without success and is considering a comprehensive blood test to explore other causes of hair loss. They are unsure about the necessity and cost of the extensive tests and are seeking advice on whether to proceed with the full panel or focus on specific tests.

community Increased adipose tissue (being overweight) in males may increase likelyhood of finasterde side effects

in Research/Science 27 upvotes 1 year ago

Being overweight may increase finasteride side effects due to higher aromatase activity converting testosterone to estradiol. Maintaining a healthy weight could reduce these side effects.

Related Research

1 / 1 results

research Plasma C19 Steroid Sulfate Levels and Indices of Androgen Bioavailability in Female Pattern Androgenic Alopecia

32 citations , January 1990 in “Clinical Endocrinology”

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.